Tag Archives: entitled forward-looking statements

Amphastar Pharmaceuticals, Inc. (AMPH) Q3 2025 Earnings Call Transcript

**Operator Greetings:**

Welcome to the Amphastar Pharmaceuticals, Inc. Third Quarter Earnings Call.

Please note the following:

– Certain statements made during this call regarding matters that are not historical facts, including—but not limited to—management’s outlook or predictions for future periods, are forward-looking statements. These statements are based solely on information that is currently available to us.
– We encourage you to review the section entitled **Forward-Looking Statements** in the press release issued today and the presentation available on the company’s website.
– Please refer to our SEC filings—which can be found on our website and the SEC’s website—for a discussion of numerous factors that may impact our future performance.
– We will also discuss certain non-GAAP measures during this call. Important information regarding our use of these measures, as well as reconciliations to U.S. GAAP, may be found in our earnings release.
– Please be aware that this conference is being recorded.

**Today’s Speakers:**

– Mr. Bill Peters, CFO
– Mr. Dan Dischner, Senior Vice President of Corporate Communications
– Mr. Tony Marrs, Executive Vice President of Regulatory Affairs and Clinical Operations

I will now turn the conference over to your host, Mr. Dan Dischner, Senior Vice President of Corporate Communications.

Please go ahead, sir.
https://seekingalpha.com/article/4840873-amphastar-pharmaceuticals-inc-amph-q3-2025-earnings-call-transcript?source=feed_all_articles